Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity
出版年份 2022 全文链接
标题
Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 2683-2693
出版商
Informa UK Limited
发表日期
2022-08-11
DOI
10.2147/dddt.s366622
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
- (2021) Sascha D. Markowitsch et al. Cancers
- Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles
- (2021) Xinglong Fan et al. BIOMEDICINE & PHARMACOTHERAPY
- Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System
- (2021) Zhen Qu et al. Drug Design Development and Therapy
- Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles
- (2020) Junjian Wang Drug Design Development and Therapy
- Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines
- (2020) Ge Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
- (2020) Yuan Hong et al. Drug Design Development and Therapy
- Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells
- (2020) Irin Tanaudommongkon et al. Biomedicines
- Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform
- (2020) Zhen Liang et al. Drug Design Development and Therapy
- Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates
- (2020) Mahmood Barani et al. Nanomaterials
- Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine
- (2019) Yuan Hong et al. BIOMEDICINE & PHARMACOTHERAPY
- Focus on Formononetin: Anticancer Potential and Molecular Targets
- (2019) Ong et al. Cancers
- Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer
- (2019) Wei Fu et al. BIOMEDICINE & PHARMACOTHERAPY
- Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system
- (2019) Jing Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline
- (2019) Ayun Cassell et al. Journal of Oncology
- Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft
- (2018) Joshua J. Souchek et al. Acta Biomaterialia
- Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer
- (2018) Guobin Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles
- (2018) Zizheng Song et al. BIOMEDICINE & PHARMACOTHERAPY
- Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways
- (2018) Ai‑Lei Wang et al. Molecular Medicine Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment
- (2017) Tongxing Cui et al. ONCOLOGY REPORTS
- Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
- (2017) Rongrong Zhang et al. Drug Design Development and Therapy
- Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo
- (2017) Sheng Tan et al. Drug Design Development and Therapy
- RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma
- (2016) Can Wang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activityin vitroandin vivo
- (2015) Jieke Yan et al. DRUG DELIVERY
- Multifunctional Nanoparticles for Prostate Cancer Therapy
- (2014) Shantanu S. Chandratre et al. AAPS PHARMSCITECH
- Up-regulating of RASD1 and Apoptosis of DU-145 Human Prostate Cancer Cells Induced by Formononetin in Vitro
- (2014) Xiao-Jia Liu et al. Asian Pacific Journal of Cancer Prevention
- Formononetin Promotes Cell Cycle Arrest via Downregulation of Akt/Cyclin D1/CDK4 in Human Prostate Cancer Cells
- (2014) Tianyu Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles
- (2013) Chunxi Liu et al. BIOMATERIALS
- Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway
- (2013) Wen-Jun Huang et al. PHARMACEUTICAL BIOLOGY
- Formononetin-induced Apoptosis of Human Prostate Cancer Cells Through ERK1/2 Mitogen-activated Protein Kinase Inactivation
- (2012) Y. Ye et al. HORMONE AND METABOLIC RESEARCH
- Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel
- (2011) Hyun-Jong Cho et al. BIOMATERIALS
- TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer
- (2011) Stephane Oudard Future Oncology
- Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity
- (2011) Lili Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
- (2009) A. Horwich et al. ANNALS OF ONCOLOGY
- Quantitative determination of formononetin and its metabolite in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry
- (2009) Sheelendra Pratap Singh et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery
- (2009) Wangyang Yu et al. NANOTECHNOLOGY
- Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer
- (2008) Weiwei Zou et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started